TET2 Regulates Mast Cell Differentiation and Proliferation through Catalytic and Non-catalytic Activities

Cell Reports

Volumn 15, Issue 7, 2016, Pages 1566-1579

  Montagner, Sara ^a,b   Leoni, Cristina ^a,b   Emming, Stefan ^a,b   Della Chiara, Giulia ^c   Balestrieri, Chiara ^c   Barozzi, Iros ^c   Piccolo, Viviana ^c   Togher, Susan ^d   Ko, Myunggon ^d,e   Rao, Anjana ^d   Natoli, Gioacchino ^c   Monticelli, Silvia ^a  

^a INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^d LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^e Ulsan National Institute of Science and Technology   (South Korea)

Author keywords

Differentiation; DNA hydroxymethylation; Epigenetics; Mast cells; Proliferation; TET

Indexed keywords

5 HYDROXYMETHYLCYTOSINE; CCAAT ENHANCER BINDING PROTEIN; CCAAT ENHANCER BINDING PROTEIN ALPHA; CELL ADHESION MOLECULE; CHYMASE; DIOXYGENASE; INTERLEUKIN 13; INTERLEUKIN 6; MICRORNA; MYELOPEROXIDASE; PROTEIN TYROSINE PHOSPHATASE; SERINE PROTEINASE; TET2 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; 5 METHYLCYTOSINE; 5-HYDROXYMETHYLCYTOSINE; ASCORBIC ACID; CEBPA PROTEIN, MOUSE; CYTOKINE; DNA BINDING PROTEIN; ONCOPROTEIN; TET2 PROTEIN, MOUSE; TET3 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INACTIVATION; GENE EXPRESSION; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FAMILY; WILD TYPE; ANALOGS AND DERIVATIVES; BIOCATALYSIS; CYTOLOGY; DEFICIENCY; DRUG EFFECTS; GENE DELETION; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC TRANSCRIPTION; GENETICS; GENOME; HEK293 CELL LINE; HUMAN; MALE; METABOLISM; SEQUENCE ANALYSIS;

5-METHYLCYTOSINE; ASCORBIC ACID; BIOCATALYSIS; CCAAT-ENHANCER-BINDING PROTEINS; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOKINES; DNA-BINDING PROTEINS; GENE DELETION; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; GENOME; HEK293 CELLS; HUMANS; MALE; MAST CELLS; PROTO-ONCOGENE PROTEINS; SEQUENCE ANALYSIS, RNA; TRANSCRIPTION, GENETIC;

EID: 84964963496     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2016.04.044     Document Type: Article

References (59)

1. Abdel-Wahab O., Mullally A., Hedvat C., Garcia-Manero G., Patel J., Wadleigh M., Malinge S., Yao J., Kilpivaara O., Bhat R., et al. Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies. Blood 2009, 114:144-147.
2. Amati B., Frank S.R., Donjerkovic D., Taubert S. Function of the c-Myc oncoprotein in chromatin remodeling and transcription. Biochim. Biophys. Acta 2001, 1471:M135-M145.
3. An J., González-Avalos E., Chawla A., Jeong M., López-Moyado I.F., Li W., Goodell M.A., Chavez L., Ko M., Rao A. Acute loss of TET function results in aggressive myeloid cancer in mice. Nat. Commun. 2015, 6:10071.
4. Barozzi I., Simonatto M., Bonifacio S., Yang L., Rohs R., Ghisletti S., Natoli G. Coregulation of transcription factor binding and nucleosome occupancy through DNA features of mammalian enhancers. Mol. Cell 2014, 54:844-857.
5. Blaschke K., Ebata K.T., Karimi M.M., Zepeda-Martínez J.A., Goyal P., Mahapatra S., Tam A., Laird D.J., Hirst M., Rao A., et al. Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells. Nature 2013, 500:222-226.
6. Boyle E.I., Weng S., Gollub J., Jin H., Botstein D., Cherry J.M., Sherlock G. GO:TermFinder--open source software for accessing Gene Ontology information and finding significantly enriched Gene Ontology terms associated with a list of genes. Bioinformatics 2004, 20:3710-3715.
7. Cashman N.R., Durham H.D., Blusztajn J.K., Oda K., Tabira T., Shaw I.T., Dahrouge S., Antel J.P. Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Dev. Dyn. 1992, 194:209-221.
8. Chen Q., Chen Y., Bian C., Fujiki R., Yu X. TET2 promotes histone O-GlcNAcylation during gene transcription. Nature 2013, 493:561-564.
9. De Vita S., Schneider R.K., Garcia M., Wood J., Gavillet M., Ebert B.L., Gerbaulet A., Roers A., Levine R.L., Mullally A., Williams D.A. Loss of function of TET2 cooperates with constitutively active KIT in murine and human models of mastocytosis. PLoS ONE 2014, 9:e96209.
10. Deho' L., Leoni C., Brodie T.M., Montagner S., De Simone M., Polletti S., Barozzi I., Natoli G., Monticelli S. Two functionally distinct subsets of mast cells discriminated By IL-2-independent CD25 activities. J. Immunol. 2014, 193:2196-2206.
11. Deplus R., Delatte B., Schwinn M.K., Defrance M., Méndez J., Murphy N., Dawson M.A., Volkmar M., Putmans P., Calonne E., et al. TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1/COMPASS. EMBO J. 2013, 32:645-655.
12. Gallant P., Steiger D. Myc's secret life without Max. Cell Cycle 2009, 8:3848-3853.
13. Garber M., Yosef N., Goren A., Raychowdhury R., Thielke A., Guttman M., Robinson J., Minie B., Chevrier N., Itzhaki Z., et al. A high-throughput chromatin immunoprecipitation approach reveals principles of dynamic gene regulation in mammals. Mol. Cell 2012, 47:810-822.
14. Hahn M.A., Qiu R., Wu X., Li A.X., Zhang H., Wang J., Jui J., Jin S.G., Jiang Y., Pfeifer G.P., Lu Q. Dynamics of 5-hydroxymethylcytosine and chromatin marks in Mammalian neurogenesis. Cell Rep. 2013, 3:291-300.
15. Heintzman N.D., Stuart R.K., Hon G., Fu Y., Ching C.W., Hawkins R.D., Barrera L.O., Van Calcar S., Qu C., Ching K.A., et al. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat. Genet. 2007, 39:311-318.
16. Heintzman N.D., Hon G.C., Hawkins R.D., Kheradpour P., Stark A., Harp L.F., Ye Z., Lee L.K., Stuart R.K., Ching C.W., et al. Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 2009, 459:108-112.
17. Heinz S., Benner C., Spann N., Bertolino E., Lin Y.C., Laslo P., Cheng J.X., Murre C., Singh H., Glass C.K. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 2010, 38:576-589.
18. Hon G.C., Song C.X., Du T., Jin F., Selvaraj S., Lee A.Y., Yen C.A., Ye Z., Mao S.Q., Wang B.A., et al. 5mC oxidation by Tet2 modulates enhancer activity and timing of transcriptome reprogramming during differentiation. Mol. Cell 2014, 56:286-297.
19. Huang Y., Rao A. Connections between TET proteins and aberrant DNA modification in cancer. Trends Genet. 2014, 30:464-474.
20. Huang Y., Chavez L., Chang X., Wang X., Pastor W.A., Kang J., Zepeda-Martínez J.A., Pape U.J., Jacobsen S.E., Peters B., Rao A. Distinct roles of the methylcytosine oxidases Tet1 and Tet2 in mouse embryonic stem cells. Proc. Natl. Acad. Sci. USA 2014, 111:1361-1366.
21. Ito S., Shen L., Dai Q., Wu S.C., Collins L.B., Swenberg J.A., He C., Zhang Y. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 2011, 333:1300-1303.
22. Iwasaki H., Mizuno S., Arinobu Y., Ozawa H., Mori Y., Shigematsu H., Takatsu K., Tenen D.G., Akashi K. The order of expression of transcription factors directs hierarchical specification of hematopoietic lineages. Genes Dev. 2006, 20:3010-3021.
23. Ko M., Huang Y., Jankowska A.M., Pape U.J., Tahiliani M., Bandukwala H.S., An J., Lamperti E.D., Koh K.P., Ganetzky R., et al. Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2. Nature 2010, 468:839-843.
24. Ko M., Bandukwala H.S., An J., Lamperti E.D., Thompson E.C., Hastie R., Tsangaratou A., Rajewsky K., Koralov S.B., Rao A. Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice. Proc. Natl. Acad. Sci. USA 2011, 108:14566-14571.
25. Ko M., An J., Pastor W.A., Koralov S.B., Rajewsky K., Rao A. TET proteins and 5-methylcytosine oxidation in hematological cancers. Immunol. Rev. 2015, 263:6-21.
26. Langmead B., Salzberg S.L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 2012, 9:357-359.
27. Leoni C., Montagner S., Deho' L., D'Antuono R., De Matteis G., Marzano A.V., Merante S., Orlandi E.M., Zanotti R., Monticelli S. Reduced DNA methylation and hydroxymethylation in patients with systemic mastocytosis. Eur. J. Haematol. 2015, 95:566-575.
28. Li H., Handsaker B., Wysoker A., Fennell T., Ruan J., Homer N., Marth G., Abecasis G., Durbin R. The Sequence Alignment/Map format and SAMtools. Bioinformatics 2009, 25:2078-2079. 1000 Genome Project Data Processing Subgroup.
29. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
30. Lu F., Liu Y., Jiang L., Yamaguchi S., Zhang Y. Role of Tet proteins in enhancer activity and telomere elongation. Genes Dev. 2014, 28:2103-2119.
31. Mayoral R.J., Monticelli S. Stable overexpression of miRNAs in bone marrow-derived murine mast cells using lentiviral expression vectors. Methods Mol. Biol. 2010, 667:205-214.
32. Mayoral R.J., Deho L., Rusca N., Bartonicek N., Saini H.K., Enright A.J., Monticelli S. MiR-221 influences effector functions and actin cytoskeleton in mast cells. PLoS ONE 2011, 6:e26133.
33. McLean C.Y., Bristor D., Hiller M., Clarke S.L., Schaar B.T., Lowe C.B., Wenger A.M., Bejerano G. GREAT improves functional interpretation of cis-regulatory regions. Nat. Biotechnol. 2010, 28:495-501.
34. Ostuni R., Piccolo V., Barozzi I., Polletti S., Termanini A., Bonifacio S., Curina A., Prosperini E., Ghisletti S., Natoli G. Latent enhancers activated by stimulation in differentiated cells. Cell 2013, 152:157-171.
35. Pastor W.A., Aravind L., Rao A. TETonic shift: biological roles of TET proteins in DNA demethylation and transcription. Nat. Rev. Mol. Cell Biol. 2013, 14:341-356.
36. Paul F., Arkin Y., Giladi A., Jaitin D.A., Kenigsberg E., Keren-Shaul H., Winter D., Lara-Astiaso D., Gury M., Weiner A., et al. Transcriptional Heterogeneity and Lineage Commitment in Myeloid Progenitors. Cell 2015, 163:1663-1677.
37. Qi X., Hong J., Chaves L., Zhuang Y., Chen Y., Wang D., Chabon J., Graham B., Ohmori K., Li Y., Huang H. Antagonistic regulation by the transcription factors C/EBPα and MITF specifies basophil and mast cell fates. Immunity 2013, 39:97-110.
38. Quinlan A.R., Hall I.M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 2010, 26:841-842.
39. Rasmussen K.D., Jia G., Johansen J.V., Pedersen M.T., Rapin N., Bagger F.O., Porse B.T., Bernard O.A., Christensen J., Helin K. Loss of TET2 in hematopoietic cells leads to DNA hypermethylation of active enhancers and induction of leukemogenesis. Genes Dev. 2015, 29:910-922.
40. Ren B., Cam H., Takahashi Y., Volkert T., Terragni J., Young R.A., Dynlacht B.D. E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints. Genes Dev. 2002, 16:245-256.
41. Rishi V., Bhattacharya P., Chatterjee R., Rozenberg J., Zhao J., Glass K., Fitzgerald P., Vinson C. CpG methylation of half-CRE sequences creates C/EBPalpha binding sites that activate some tissue-specific genes. Proc. Natl. Acad. Sci. USA 2010, 107:20311-20316.
42. Rusca N., Dehò L., Montagner S., Zielinski C.E., Sica A., Sallusto F., Monticelli S. MiR-146a and NF-κB1 regulate mast cell survival and T lymphocyte differentiation. Mol. Cell. Biol. 2012, 32:4432-4444.
43. Song C.X., Szulwach K.E., Fu Y., Dai Q., Yi C., Li X., Li Y., Chen C.H., Zhang W., Jian X., et al. Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine. Nat. Biotechnol. 2011, 29:68-72.
44. Soucie E., Hanssens K., Mercher T., Georgin-Lavialle S., Damaj G., Livideanu C., Chandesris M.O., Acin Y., Létard S., de Sepulveda P., et al. In aggressive forms of mastocytosis, TET2 loss cooperates with c-KITD816V to transform mast cells. Blood 2012, 120:4846-4849.
45. Spruijt C.G., Gnerlich F., Smits A.H., Pfaffeneder T., Jansen P.W., Bauer C., Münzel M., Wagner M., Müller M., Khan F., et al. Dynamic readers for 5-(hydroxy)methylcytosine and its oxidized derivatives. Cell 2013, 152:1146-1159.
46. Supek F., Bošnjak M., Škunca N., Šmuc T. REVIGO summarizes and visualizes long lists of gene ontology terms. PLoS ONE 2011, 6:e21800.
47. Tahiliani M., Koh K.P., Shen Y., Pastor W.A., Bandukwala H., Brudno Y., Agarwal S., Iyer L.M., Liu D.R., Aravind L., Rao A. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 2009, 324:930-935.
48. Theoharides T.C., Valent P., Akin C. Mast Cells, Mastocytosis, and Related Disorders. N. Engl. J. Med. 2015, 373:163-172.
49. Trapnell C., Roberts A., Goff L., Pertea G., Kim D., Kelley D.R., Pimentel H., Salzberg S.L., Rinn J.L., Pachter L. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat. Protoc. 2012, 7:562-578.
50. Trapnell C., Hendrickson D.G., Sauvageau M., Goff L., Rinn J.L., Pachter L. Differential analysis of gene regulation at transcript resolution with RNA-seq. Nat. Biotechnol. 2013, 31:46-53.
51. Tsai M., Takeishi T., Thompson H., Langley K.E., Zsebo K.M., Metcalfe D.D., Geissler E.N., Galli S.J. Induction of mast cell proliferation, maturation, and heparin synthesis by the rat c-kit ligand, stem cell factor. Proc. Natl. Acad. Sci. USA 1991, 88:6382-6386.
52. Williams K., Christensen J., Pedersen M.T., Johansen J.V., Cloos P.A., Rappsilber J., Helin K. TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity. Nature 2011, 473:343-348.
53. Wu H., D'Alessio A.C., Ito S., Xia K., Wang Z., Cui K., Zhao K., Sun Y.E., Zhang Y. Dual functions of Tet1 in transcriptional regulation in mouse embryonic stem cells. Nature 2011, 473:389-393.
54. Yamanaka R., Barlow C., Lekstrom-Himes J., Castilla L.H., Liu P.P., Eckhaus M., Decker T., Wynshaw-Boris A., Xanthopoulos K.G. Impaired granulopoiesis, myelodysplasia, and early lethality in CCAAT/enhancer binding protein epsilon-deficient mice. Proc. Natl. Acad. Sci. USA 1997, 94:13187-13192.
55. Yin R., Mao S.Q., Zhao B., Chong Z., Yang Y., Zhao C., Zhang D., Huang H., Gao J., Li Z., et al. Ascorbic acid enhances Tet-mediated 5-methylcytosine oxidation and promotes DNA demethylation in mammals. J. Am. Chem. Soc. 2013, 135:10396-10403.
56. Yue X., Trifari S., Äijö T., Tsagaratou A., Pastor W.A., Zepeda-Martínez J.A., Lio C.W., Li X., Huang Y., Vijayanand P., et al. Control of Foxp3 stability through modulation of TET activity. J. Exp. Med. 2016, 213:377-397.
57. Zambelli F., Pesole G., Pavesi G. Pscan: finding over-represented transcription factor binding site motifs in sequences from co-regulated or co-expressed genes. Nucleic Acids Res. 2009, 37:W247-252.
58. Zhang Y., Liu T., Meyer C.A., Eeckhoute J., Johnson D.S., Bernstein B.E., Nusbaum C., Myers R.M., Brown M., Li W., Liu X.S. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 2008, 9:R137.
59. Zhang Q., Zhao K., Shen Q., Han Y., Gu Y., Li X., Zhao D., Liu Y., Wang C., Zhang X., et al. Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6. Nature 2015, 525:389-393.